home All News open_in_new Full Article

Detección temprana del Alzheimer: la FDA admite prueba sanguínea para deterioro cognitivo

Uno de los principales indicadores del Alzheimer podría ser detectado mediante una prueba de sangre que revela la acumulación de placas de amiloide en el cerebro.


today 9 d. ago attach_file Other

attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other


ID: 2943964449
Add Watch Country

arrow_drop_down